| T38343 |
Quercetin pentaacetate
|
1064-06-8
|
98%
|
|
|
Quercetin pentaacetate (Pentaacetylquercetin) has diverse biological activities, including antioxidant, anti-inflammatory, and anticancer properties. Quercetin p...
|
| TN3048 |
4-Methoxycinnamaldehyde
|
1963-36-6
|
98%
|
|
|
4-Methoxycinnamaldehyde (p-Methoxycinnamaldehyde) is an active ingredient of Agastache rugosa.4-Methoxycinnamaldehyde has cytoprotective activity against respira...
|
| T77100 |
Nirsevimab
|
1989556-22-0
|
98%
|
Nirsevimab
|
|
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region. Nirsevimab efficiently targets RSV-...
|
| T76992 |
Suptavumab
|
1629615-23-1
|
98%
|
Suptavumab
|
|
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab neutralizes conserved epitopes on subtypes A and B on RSV. Suptavumab can be used to study RSV i...
|
| T76907 |
Palivizumab
|
188039-54-5
|
98%
|
|
|
Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and...
|
| T2621 |
Rostafuroxin
|
156722-18-8
|
98%
|
|
|
Rostafuroxin (PST 2238) has been used in trials studying the treatment of Essential Hypertension.
|
| T12774 |
RSV-IN-1
|
861139-16-4
|
98%
|
|
|
RSV-IN-1 is an inhibitor of human respiratory syncytical virus (hRSV) and reduced the virus infectivity with IC50 value of 0.11 μM.
|
| T63253 |
AVG-233
|
2151937-80-1
|
98%
|
|
|
AVG-233 is an orally available RNA-dependent RNA polymerase (RdRp) inhibitor with antiviral activity that blocks respiratory syncytial virus and SARS-CoV-2 repli...
|
| T7353 |
RSV604
|
676128-63-5
|
98%
|
|
|
RSV604 ((S)-1-(2-Fluorophenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)urea) is an inhibitor of respiratory syncytial virus (RSV) that binds ...
|
| T3417 |
Amentoflavone
|
1617-53-4
|
99.22%
|
|
|
Amentoflavone (3',8''-Biapigenin), as a potent inhibitor of CYP3A4 and CYP2C9, can interact with many other medications. CYP3A4 and CYP2C9 are proteins used for ...
|
| TQ0085 |
Presatovir
|
1353625-73-6
|
99.38%
|
|
|
Presatovir (GS-5806) (GS-5806) is a novel, orally bioavailable RSV fusion inhibitor (mean EC50: 0.43 nM).
|
| T60016 |
VV116
|
2647442-33-7
|
99.42%
|
|
|
VV116 (JT001) is a selective and orally active nucleoside antiviral agent against respiratory syncytial virus (RSV) and SARS-CoV-2 infection.
|
| T11760 |
KIN101
|
610753-87-2
|
99.46%
|
|
|
KIN101 (3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene), an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KI...
|
| T9197 |
Sisunatovir hydrochloride
|
1903763-83-6
|
99.49%
|
|
|
Sisunatovir hydrochloride (RV521 HCl) is an orally available inhibitor of the RSV-F protein that has exhibited potent efficacy against a panel of clinical isolat...
|
| T1024 |
Roflumilast
|
162401-32-3
|
99.64%
|
|
|
Roflumilast (APTA 2217) is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplast...
|
| T4380 |
Ac-CoA Synthase Inhibitor1
|
508186-14-9
|
99.81%
|
|
|
Ac-CoA Synthase Inhibitor1 (ACSS2 inhibitor) is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2).
|
| T15621 |
Rilematovir
|
1383450-81-4
|
99.82%
|
|
|
Rilematovir (JNJ-678) is an inhibitor of fusion protein with antiviral activity and low cytotoxicity. Rilematovir can be used in studies about respiratory syncyt...
|
| T0684 |
Ribavirin
|
36791-04-5
|
99.83%
|
|
|
Ribavirin (Tribavirin) is a synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses.
|
| T26914 |
BTA-9881
|
1646857-24-0
|
v
|
|
|
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
|
| TQ0034 |
Lumicitabine
|
1445385-02-3
|
98%
|
|
|
Lumicitabine (ALS-008176) is an inhibitor of RSV polymerase.
|
